Dynamic Treg interactions with intratumoral APCs promote local CTL dysfunction - Wikidata - awgldk - TriplyDB

Dynamic Treg interactions with intratumoral APCs promote local CTL dysfunction

Dynamic Treg interactions with intratumoral APCs promote local CTL dysfunction

http://www.wikidata.org/entity/Q30583272

about

New insights into the mechanisms of Treg function T-cell exhaustion in allograft rejection and tolerance CD11c-Expressing Cells Affect Regulatory T Cell Behavior in the Meninges during Central Nervous System Infection.CD28-CD80 interactions control regulatory T cell motility and immunological synapse formation.Visualization and tracking of tumour extracellular vesicle delivery and RNA translation using multiplexed reporters.Tumor-infiltrating lymphocytes are dynamically desensitized to antigen but are maintained by homeostatic cytokine.Targeted calcium influx boosts cytotoxic T lymphocyte function in the tumour microenvironment.Visualizing T Cell Migration in situ Imaging regulatory T cell dynamics and CTLA4-mediated suppression of T cell priming.Immunomodulatory antibody therapy of cancer: the closer, the better T cell metabolic fitness in antitumor immunity.Impact of a New Fusion Receptor on PD-1-Mediated Immunosuppression in Adoptive T Cell Therapy TIGIT predominantly regulates the immune response via regulatory T cells.Graded Foxo1 activity in Treg cells differentiates tumour immunity from spontaneous autoimmunity.Prevention of allograft rejection in heart transplantation through concurrent gene silencing of TLR and Kinase signaling pathways.Long-term intravital imaging of the multicolor-coded tumor microenvironment during combination immunotherapy.In Vivo Imaging Sheds Light on Immune Cell Migration and Function in Cancer.Controlling the fire--tissue-specific mechanisms of effector regulatory T-cell homing.The transcription factor NFAT promotes exhaustion of activated CD8⁺ T cells.CTLA-4/CD80 pathway regulates T cell infiltration into pancreatic cancer.Immune suppressive mechanisms in the tumor microenvironment.Cancer Immunotherapy: Whence and Whither.Harnessing co-stimulatory TNF receptors for cancer immunotherapy: Current approaches and future opportunities.Mechanisms of tumor escape in the context of the T-cell-inflamed and the non-T-cell-inflamed tumor microenvironment.Cytokines and metabolic factors regulate tumoricidal T-cell function during cancer immunotherapy.Targeting the tumor microenvironment: removing obstruction to anticancer immune responses and immunotherapy.Reversing T-cell Dysfunction and Exhaustion in Cancer.Pharmacological Modulation of Proton Channel Hv1 in Cancer Therapy: Future Perspectives.Viewing immune regulation as it happens: in vivo imaging for investigation of regulatory T-cell function.IDO, PTEN-expressing Tregs and control of antigen-presentation in the murine tumor microenvironment.Comparative Analysis of Immune Checkpoint Molecules and Their Potential Role in the Transmissible Tasmanian Devil Facial Tumor Disease.Transcriptional and epigenetic regulation of T cell hyporesponsiveness.Blockade of surface-bound TGF-β on regulatory T cells abrogates suppression of effector T cell function in the tumor microenvironment.CDK4/6 inhibition triggers anti-tumour immunity.Cytokine-induced killer cell therapy for modulating regulatory T cells in patients with non-small cell lung cancer Crosstalk between Regulatory T Cells and Tumor-Associated Dendritic Cells Negates Anti-tumor Immunity in Pancreatic Cancer.Identification and characterization of T reg-like cells in zebrafish.Requirement of Treg-intrinsic CTLA4/PKCη signaling pathway for suppressing tumor immunity.ATP Release from Chemotherapy-Treated Dying Leukemia Cells Elicits an Immune Suppressive Effect by Increasing Regulatory T Cells and Tolerogenic Dendritic Cells.CD4 and CD8 T lymphocyte interplay in controlling tumor growth.

P2860

Q26823540-F5A794D2-CBF1-41F3-8D79-2CF893D666B5 Q26865338-B5C45434-3C94-452B-9D72-67807501D907 Q30252696-D9BBAB37-28A0-4010-9CC2-42BBAFF48FF0 Q30605826-57F795FF-8869-4DC7-BC31-F66740669DFD Q30650963-28D43D3D-1D8E-4520-AAA2-F51A44926EEE Q30830664-45D889C9-01FD-4EFD-9401-06E85B9AAA14 Q33715943-289DF51A-0A39-47A4-B0C5-FFE97A5FF4E8 Q33965597-4AA7FD72-D026-4785-879E-36DFAB8CDB5B Q35141650-587B3836-0A76-48BB-B379-98F53BE47146 Q35142851-E3FDB9EE-56A8-4CA1-817F-4F6888852046 Q35371293-B9B96DAB-E20E-4FC6-9B16-C63926F5BDAA Q36173500-FFFD0BFF-4ED9-49D9-A7CD-28059E518A5D Q36266506-A45A0CAE-91EA-4CB3-A7AE-A0F88821EAE8 Q37162527-711511F3-11C3-492B-9B82-677E23590198 Q37277855-57EDFD8B-2779-4072-B536-7A60EFB575AD Q37520816-FF82B7BF-A7ED-4E45-A4AB-F8D33AD7BB14 Q37714428-C0B6A974-D2C5-4D21-85FB-E781C27DD00C Q38315880-27DBD1E9-3FD6-46BA-B926-E18DD5B668A0 Q38445342-A50DEE78-91D7-46B3-B396-C471FC7CE61E Q38601221-624A9B54-2207-4A3B-A527-58803AB61C38 Q38648567-B50627B9-83C0-4A1C-997A-52A8143CE609 Q38737924-6AF533B3-A8EF-4177-AA88-D54F393C8614 Q38770814-EC215ABD-0D24-4A3E-B24E-B3D815E9669F Q38779257-E6886FC4-1EE7-4D82-90AF-28295E76EC98 Q38779877-653F07DB-8851-4026-8F8B-27BAD1D48938 Q38805897-90B50F06-98EB-4AFD-AC8E-A5A4DB4D1B8F Q38809776-55E7FB9B-AE31-404C-84C0-0AA16FD9CA68 Q38853680-E1FAC41D-E442-4915-9D28-7C710A5580E9 Q39249455-596E8C1D-4BAE-4C84-A192-EF9934727E7A Q39294822-DFD631CD-D74C-4603-8091-928E6EADCB5E Q39313794-8AC83544-2BDF-494C-BE86-13B2BF9F3A39 Q39367810-45E87BC3-4572-443A-A3F1-C933B23C3089 Q40066040-0FAD6E0E-4EB5-4504-A4CC-0C636C7DD4EA Q40081387-1B8FCD73-E796-4CC6-A4C1-04450448E2BB Q41016369-5D29EC45-3B7D-4F30-A038-D0620A832BA0 Q42660198-1EE52445-108A-413F-8672-C62C2D99ABEE Q46188870-3D94E83C-21BB-4AA4-9E96-A336F9605A48 Q46909626-B0029A8D-C9A5-4F9E-A69E-2282746833F5 Q47194065-9F2CF4EA-3A5D-4B4A-A2BE-00C2A92077D7 Q48185876-1C34FD3F-5B9D-419A-82D4-8027C464639A

P2860

Dynamic Treg interactions with intratumoral APCs promote local CTL dysfunction

http://www.wikidata.org/entity/Q30583272

description

2014 nî lūn-bûn

@nan

2014 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Dynamic Treg interactions with intratumoral APCs promote local CTL dysfunction

@ast

Dynamic Treg interactions with intratumoral APCs promote local CTL dysfunction

@en

type

label

Dynamic Treg interactions with intratumoral APCs promote local CTL dysfunction

@ast

Dynamic Treg interactions with intratumoral APCs promote local CTL dysfunction

@en

prefLabel

Dynamic Treg interactions with intratumoral APCs promote local CTL dysfunction

@ast

Dynamic Treg interactions with intratumoral APCs promote local CTL dysfunction

@en

P1433

Q30583272-6A3022F1-7EF5-45AE-BEF3-44C74E6CB92F

P1476

Q30583272-3785F795-2DE4-46CB-8632-3488A2799CFE

P2093

Q30583272-2E11D36D-8D32-4AF4-8794-A61503457E17

Q30583272-43BF8BA1-6A92-43F7-9CC5-1085C465D16C

Q30583272-549CB063-3FDD-48D2-B760-8B319204E495

Q30583272-67AFC8A0-79FF-463E-A538-0C9451589FA4

Q30583272-83AFDE24-CA17-42C6-B672-D960366B1425

P2860

Q30583272-010A1AC7-1BA4-4ED7-90E5-EB58B6FB8910

Q30583272-03BE5E65-FE98-414B-A731-32B781E7FF63

Q30583272-0CEE7F0C-9F15-445B-951E-9F2385F7A90B

Q30583272-15244ED9-28B1-4BD2-B9AE-870DB38EFBCE

Q30583272-17C6DE5D-78B2-43D2-B711-991FE9D73B4C

Q30583272-27AF0BA8-64A8-411A-A929-6AC23508112F

Q30583272-2ACEA7BE-E0A4-461F-9809-9613E52A3E72

Q30583272-2B9518B2-8953-484D-B55C-1397447DAE39

Q30583272-2BF3366D-2591-4966-AECA-3F8AE2F9D925

Q30583272-2D879D73-E4D4-45CA-88F5-84B1EF1556E8

P304

Q30583272-FDCCCAC3-D265-4E48-90A7-36C9C5019A7F

P31

Q30583272-3B08AEAC-0F82-4453-AEE4-1BE47351B48C

P356

Q30583272-2BA805E7-811B-4FA6-A893-409A54C20325

P407

Q30583272-789A205E-637D-4E7C-BDFC-05D405A277E9

P433

Q30583272-83043307-C0F3-44B8-9EA0-BA003337E3C7

P478

Q30583272-30D93807-2F75-42FF-A924-CB90490B6344

P50

Q30583272-1F9842AA-A48A-485B-A398-F4B0875257C6

P577

Q30583272-A638EA3A-E943-47CC-92A2-C1C840387221

P698

Q30583272-708AF4EF-2F26-42EF-BABE-F513599C0BE4

P932

Q30583272-D6EC9164-5D89-4B2A-9590-577B7FC88440

P356

P1433

Journal of Clinical Investigation

P1476

Dynamic Treg interactions with intratumoral APCs promote local CTL dysfunction

@en

P2093

Christian A Bauer

http://www.w3.org/2001/XMLSchema#string

Edward Y Kim

http://www.w3.org/2001/XMLSchema#string

Esteban Carrizosa

http://www.w3.org/2001/XMLSchema#string

Natalie M Claudio

http://www.w3.org/2001/XMLSchema#string

Thorsten R Mempel

http://www.w3.org/2001/XMLSchema#string

P2860

FOXP3 controls regulatory T cell function through cooperation with NFAT

Interleukin-2 receptor signaling: at the interface between tolerance and immunity

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4

T helper 17 cells promote cytotoxic T cell activation in tumor immunity

Tumor-specific Th17-polarized cells eradicate large established melanoma

Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction

Molecular mechanisms of T cell co-stimulation and co-inhibition

Tuning of antigen sensitivity by T cell receptor-dependent negative feedback controls T cell effector function in inflamed tissues.

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

P304

2425-2440

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI66375

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

124

http://www.w3.org/2001/XMLSchema#string

P50

Francesco Marangoni

P577

2014-05-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24812664

http://www.w3.org/2001/XMLSchema#string

P932

4089459

http://www.w3.org/2001/XMLSchema#string